Aimfinity Investment Corp. I Files 8-K on New Equity Units

TL;DR

Aimfinity issued new units with warrants, exercise price $11.50.

AI Summary

Aimfinity Investment Corp. I entered into a material definitive agreement on October 6, 2025, related to the issuance of new units. These units consist of one Class A ordinary share and one-half of one Class 2 redeemable warrant, with an exercise price of $11.50 per share. The filing also details unregistered sales of equity securities and includes financial statements and exhibits.

Why It Matters

This filing indicates Aimfinity Investment Corp. I is issuing new equity, which could impact its share structure and potentially raise capital.

Risk Assessment

Risk Level: medium — The issuance of new equity and warrants can dilute existing shareholders and introduce uncertainty regarding future share prices.

Key Numbers

• $11.50 — Warrant Exercise Price (This is the price at which holders can exercise their warrants to purchase Class A ordinary shares.)

Key Players & Entities

• Aimfinity Investment Corp. I (company) — Filer
• October 6, 2025 (date) — Date of earliest event reported
• $11.50 (dollar_amount) — Exercise price for warrants

FAQ

Key Financial Figures

• $11.50 — ordinary share at an exercise price of $11.50 AIMUF OTC Market Group, Inc. New
• $0.0001 — ) of 687,054 ordinary shares, par value $0.0001 per share, of the Company (the "Conside

Filing Documents

• ea0260964-8k425_aimfinity1.htm (8-K) — 45KB
• ea026096401ex10-1_aimfinity1.htm (EX-10.1) — 14KB
• ea026096401ex99-1_aimfinity1.htm (EX-99.1) — 98KB
• 0001213900-25-098164.txt ( ) — 407KB
• aimuf-20251006.xsd (EX-101.SCH) — 4KB
• aimuf-20251006_def.xml (EX-101.DEF) — 27KB
• aimuf-20251006_lab.xml (EX-101.LAB) — 38KB
• aimuf-20251006_pre.xml (EX-101.PRE) — 26KB
• ea0260964-8k425_aimfinity1_htm.xml (XML) — 7KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement As previously disclosed by Aimfinity Investment Corp. I ("AIMA" or the "Company") in its Current Report on Form 8-K filed on October 16, 2023, on October 13, 2023, the Company entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), with Docter Inc., a Delaware corporation ("Docter"), Aimfinity Investment Merger Sub I, a Cayman Islands exempted company and wholly-owned subsidiary of AIMA ("Purchaser"), and Aimfinity Investment Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser ("Merger Sub"), pursuant to which AIMA will complete a business combination (the "Business Combination") with Docter that involves a reincorporation merger and an acquisition merger. The Purchaser shall survive the Business Combination and be referred to as "PubCo" after the Business Combination. As previously disclosed, on May 27, 2025, PubCo, Mr. I-Fa Chang, CEO and Chairman of AIMA (the "Seller"), and Inkrock Holding Limited, a British Virgin Islands company ("Inkrock", together with PubCo and Seller, the "Parties"), entered into a securities purchase agreement (the "May 27 Agreement") pursuant to which the Seller agreed to transfer (the "Transfer") all the securities it holds in Inkrock to PubCo, in exchange for the issuance (the "Issuance") of 687,054 ordinary shares, par value $0.0001 per share, of the Company (the "Consideration Shares") on the date of the agreement. As of the date hereof, the Transfer has not been effected. For accounting purposes, and in light of the fact that the transactions provided in the May 27 Agreement have not been fully consummated, on October 6, 2025, the Parties agreed to enter into a termination agreement to unwind the transactions provided in the May 27 Agreement and to discharge each Party from further obligations under the May 27 Agreement. In its place, the Parties e

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. 1 IMPORTANT NOTICES As disclosed previously on the Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023, on October 13, 2023, AIMA entered into that certain Merger Agreement, with Docter, Purchaser, and Merger Sub, pursuant to which AIMA will complete a business combination with Docter that involves a reincorporation merger and an acquisition merger. This Current Report on Form 8-K contains certain "forward-looking about the proposed transactions described above, and the parties' perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transactions, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the proposed transactions. The words "expect," "believe," "estimate," "intend," "plan" and similar expressions indicate forward-looking statements. These forward-looking about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated. Such risks and uncertainties include, but are not limited to: (i) risks related to the expected timing and likelihood

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Termination Agreement, dated October 6, 2025, by and among Registrant, Inkrock and Seller 99.1 Securities Purchase Agreement, dated October 7, 2025, by and among Registrant, Inkrock and Seller 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aimfinity Investment Corp. I Date: October 10, 2025 By: /s/ I-Fa Chang Name: I-Fa Chang Title: Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR